MSTN and Abdominal obesity: Since myostatin was independently related to MetS, we estimated the odds ratio (OR) for metabolic disorders, including MetS, central obesity, low HDL cholesterol, hypertriglyceridemia, and DM, associated with different concentrations of myostatin in logistic regression models.